Evidence map›Paper›PMID 34791092›Full record

ReviewEndocrine reviews2022

Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease.

Franck Mauvais-Jarvis, Carol A Lange, Ellis R Levin

Abstract readReview
In one paragraph

Review in Endocrine reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Gendering the Menstrual Cycle in Behavioral Neuroendocrinology.American journal of human biology : the official journal of the Human Biology Council · 2026
    Review
  8. MET goes to the membrane-A new place for the "old" juvenile hormone receptor.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Review
  11. Metabolic Messengers: testosterone.Nature metabolism · 2026
    Review
  12. Review
  13. Membrane-localized MET engages PVR to mediate extranuclear juvenile hormone signaling inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Review
  15. Review
  16. Context rescales a social action code in a hormone-sensitive network.bioRxiv : the preprint server for biology · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Androgens as the "old age stick" in skeletal muscle.Cell communication and signaling : CCS · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Franck Mauvais-JarvisDepartment of Medicine, Section of Endocrinology and Metabolism, Tulane University School of Medicine, New Orleans, LA, 70112, USA.ORCID 0000-0002-0874-0754
Carol A LangeMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Ellis R LevinDivision of Endocrinology, Department of Medicine, University of California, Irvine, Irvine, CA, 92697, USA.

Funding

Targeting the estrogen receptor-α to protect functional β-cell mass in womenR01DK074970 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI Franck Mauvais-Jarvis · 2007 to 2026
$6.0M
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast CancerR01CA229697 · NCI · UNIVERSITY OF MINNESOTA · PI Carol A Lange, Douglas Yee · 2020 to 2026
$3.6M
Role of Phospho-Progesterone Receptors (PR) in Hormone Refractory Breast CancerR01CA159712 · NCI · UNIVERSITY OF MINNESOTA · PI LANGE, CAROL A · 2012 to 2016
$1.9M
Repurposing estrogens to improve pancreatic islet transplantationR01DK107444 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI MAUVAIS-JARVIS, FRANCK · 2016 to 2019
$1.5M
Estrogen receptor and the cardiovascular systemI01BX002316 · VA · VETERANS HEALTH ADMINISTRATION · PI LEVIN, ELLIS R · 2014 to 2022
–
The role of the androgen receptor in insulin secretionI01BX003725 · VA · SOUTHEAST LOUISIANA VETERANS HEALTH CARE · PI MAUVAIS-JARVIS, FRANCK · 2018 to 2022
–
BLRD VA I01 BX002316BLRD VA I01 BX003725NCI NIH HHS R01 CA159712NCI NIH HHS R01 CA229697NIDDK NIH HHS R01 DK074970NIDDK NIH HHS R01 DK107444
6 · The paper itself

Abstract

Rapid effects of steroid hormones were discovered in the early 1950s, but the subject was dominated in the 1970s by discoveries of estradiol and progesterone stimulating protein synthesis. This led to the paradigm that steroid hormones regulate growth, differentiation, and metabolism via binding a receptor in the nucleus. It took 30 years to appreciate not only that some cellular functions arise solely from membrane-localized steroid receptor (SR) actions, but that rapid sex steroid signaling from membrane-localized SRs is a prerequisite for the phosphorylation, nuclear import, and potentiation of the transcriptional activity of nuclear SR counterparts. Here, we provide a review and update on the current state of knowledge of membrane-initiated estrogen (ER), androgen (AR) and progesterone (PR) receptor signaling, the mechanisms of membrane-associated SR potentiation of their nuclear SR homologues, and the importance of this membrane-nuclear SR collaboration in physiology and disease. We also highlight potential clinical implications of pathway-selective modulation of membrane-associated SR.

Indexed as

Receptors, ProgesteroneReceptors, SteroidAndrogensEstradiolEstrogensHumansProgesteroneReceptors, AndrogenSteroidsAndrogensEstradiolEstrogensProgesteroneReceptors, AndrogenReceptors, ProgesteroneReceptors, SteroidSteroidsandrogenestrogennongenomicprogesteronerapid actions

Identifiers

PMID34791092
PMCPMC9277649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.